Multiple sclerosis (MS) is a complex and disabling chronic nervous system disease.This disease acute active central nervous white matter has multiple inflammatory demyelinating spots, old lesions due to glial fiber hyperplasia and calcification spots, with multiple lesions, remission, recurrence of the course of disease as the characteristics, multiple sclerosis drug treatment can reduce the recurrence rate of this disease and slow down the process of disability.
Market Analysis and Insights: Global Multiple Sclerosis Drugs Treatment Market
The global Multiple Sclerosis Drugs Treatment market size is projected to reach US$ million by 2026, from US$ million in 2020, at a CAGR of % during 2021-2026.
Global Multiple Sclerosis Drugs Treatment Scope and Segment
The global Multiple Sclerosis Drugs Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Multiple Sclerosis Drugs Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
Interferon
Immunomodulator
Immunosuppressant
By the application, this report covers the following segments
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Other
Competitive Landscape:
The Multiple Sclerosis Drugs Treatment key manufacturers in this market include:
Pfizer
Roche
Biogen
Teva Pharmaceutical
Merck
Novartis
Bayer
Sanofi
Acorda Therapeutics
Questcor Pharmaceuticals
AbbVie
Opexa Therapeutics
Genzyme Corporation
Market Analysis and Insights: Global Multiple Sclerosis Drugs Treatment Market
The global Multiple Sclerosis Drugs Treatment market size is projected to reach US$ million by 2026, from US$ million in 2020, at a CAGR of % during 2021-2026.
Global Multiple Sclerosis Drugs Treatment Scope and Segment
The global Multiple Sclerosis Drugs Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Multiple Sclerosis Drugs Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
Interferon
Immunomodulator
Immunosuppressant
By the application, this report covers the following segments
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Other
Competitive Landscape:
The Multiple Sclerosis Drugs Treatment key manufacturers in this market include:
Pfizer
Roche
Biogen
Teva Pharmaceutical
Merck
Novartis
Bayer
Sanofi
Acorda Therapeutics
Questcor Pharmaceuticals
AbbVie
Opexa Therapeutics
Genzyme Corporation
1 Market Overview of Multiple Sclerosis Drugs Treatment
1.1 Multiple Sclerosis Drugs Treatment Market Overview
1.1.1 Multiple Sclerosis Drugs Treatment Product Scope
1.1.2 Market Status and Outlook
1.2 Global Multiple Sclerosis Drugs Treatment Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Multiple Sclerosis Drugs Treatment Market Size by Region (2015-2026)
1.4 Global Multiple Sclerosis Drugs Treatment Historic Market Size by Region (2015-2020)
1.5 Global Multiple Sclerosis Drugs Treatment Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2026)
1.6.1 North America Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2026)
1.6.2 Europe Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2026)
1.6.3 China Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2026)
1.6.5 Latin America Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2026)
2 Multiple Sclerosis Drugs Treatment Market Overview by Type
2.1 Global Multiple Sclerosis Drugs Treatment Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Multiple Sclerosis Drugs Treatment Historic Market Size by Type (2015-2020)
2.3 Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Type (2021-2026)
2.4 Interferon
2.5 Immunomodulator
2.6 Immunosuppressant
3 Multiple Sclerosis Drugs Treatment Market Overview by Application
3.1 Global Multiple Sclerosis Drugs Treatment Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Multiple Sclerosis Drugs Treatment Historic Market Size by Application (2015-2020)
3.3 Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Application (2021-2026)
3.4 Hospital Pharmacy
3.5 Retail Pharmacy
3.6 Online Pharmacy
3.7 Other
4 Global Multiple Sclerosis Drugs Treatment Competition Analysis by Players
4.1 Global Multiple Sclerosis Drugs Treatment Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Sclerosis Drugs Treatment as of 2019)
4.3 Date of Key Manufacturers Enter into Multiple Sclerosis Drugs Treatment Market
4.4 Global Top Players Multiple Sclerosis Drugs Treatment Headquarters and Area Served
4.5 Key Players Multiple Sclerosis Drugs Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Multiple Sclerosis Drugs Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business and Company’s Total Revenue
5.1.3 Pfizer Products, Services and Solutions
5.1.4 Pfizer Revenue (US$ Million) (2015-2020)
5.1.5 Pfizer Recent Development and Reaction to Covid-19
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business and Company’s Total Revenue
5.2.3 Roche Products, Services and Solutions
5.2.4 Roche Revenue (US$ Million) (2015-2020)
5.2.5 Roche Recent Development and Reaction to Covid-19
5.3 Biogen
5.5.1 Biogen Profile
5.3.2 Biogen Main Business and Company’s Total Revenue
5.3.3 Biogen Products, Services and Solutions
5.3.4 Biogen Revenue (US$ Million) (2015-2020)
5.3.5 Teva Pharmaceutical Recent Development and Reaction to Covid-19
5.4 Teva Pharmaceutical
5.4.1 Teva Pharmaceutical Profile
5.4.2 Teva Pharmaceutical Main Business and Company’s Total Revenue
5.4.3 Teva Pharmaceutical Products, Services and Solutions
5.4.4 Teva Pharmaceutical Revenue (US$ Million) (2015-2020)
5.4.5 Teva Pharmaceutical Recent Development and Reaction to Covid-19
5.5 Merck
5.5.1 Merck Profile
5.5.2 Merck Main Business and Company’s Total Revenue
5.5.3 Merck Products, Services and Solutions
5.5.4 Merck Revenue (US$ Million) (2015-2020)
5.5.5 Merck Recent Development and Reaction to Covid-19
5.6 Novartis
5.6.1 Novartis Profile
5.6.2 Novartis Main Business and Company’s Total Revenue
5.6.3 Novartis Products, Services and Solutions
5.6.4 Novartis Revenue (US$ Million) (2015-2020)
5.6.5 Novartis Recent Development and Reaction to Covid-19
5.7 Bayer
5.7.1 Bayer Profile
5.7.2 Bayer Main Business and Company’s Total Revenue
5.7.3 Bayer Products, Services and Solutions
5.7.4 Bayer Revenue (US$ Million) (2015-2020)
5.7.5 Bayer Recent Development and Reaction to Covid-19
5.8 Sanofi
5.8.1 Sanofi Profile
5.8.2 Sanofi Main Business and Company’s Total Revenue
5.8.3 Sanofi Products, Services and Solutions
5.8.4 Sanofi Revenue (US$ Million) (2015-2020)
5.8.5 Sanofi Recent Development and Reaction to Covid-19
5.9 Acorda Therapeutics
5.9.1 Acorda Therapeutics Profile
5.9.2 Acorda Therapeutics Main Business and Company’s Total Revenue
5.9.3 Acorda Therapeutics Products, Services and Solutions
5.9.4 Acorda Therapeutics Revenue (US$ Million) (2015-2020)
5.9.5 Acorda Therapeutics Recent Development and Reaction to Covid-19
5.10 Questcor Pharmaceuticals
5.10.1 Questcor Pharmaceuticals Profile
5.10.2 Questcor Pharmaceuticals Main Business and Company’s Total Revenue
5.10.3 Questcor Pharmaceuticals Products, Services and Solutions
5.10.4 Questcor Pharmaceuticals Revenue (US$ Million) (2015-2020)
5.10.5 Questcor Pharmaceuticals Recent Development and Reaction to Covid-19
5.11 AbbVie
5.11.1 AbbVie Profile
5.11.2 AbbVie Main Business and Company’s Total Revenue
5.11.3 AbbVie Products, Services and Solutions
5.11.4 AbbVie Revenue (US$ Million) (2015-2020)
5.11.5 AbbVie Recent Development and Reaction to Covid-19
5.12 Opexa Therapeutics
5.12.1 Opexa Therapeutics Profile
5.12.2 Opexa Therapeutics Main Business and Company’s Total Revenue
5.12.3 Opexa Therapeutics Products, Services and Solutions
5.12.4 Opexa Therapeutics Revenue (US$ Million) (2015-2020)
5.12.5 Opexa Therapeutics Recent Development and Reaction to Covid-19
5.13 Genzyme Corporation
5.13.1 Genzyme Corporation Profile
5.13.2 Genzyme Corporation Main Business and Company’s Total Revenue
5.13.3 Genzyme Corporation Products, Services and Solutions
5.13.4 Genzyme Corporation Revenue (US$ Million) (2015-2020)
5.13.5 Genzyme Corporation Recent Development and Reaction to Covid-19
6 North America Multiple Sclerosis Drugs Treatment by Players and by Application
6.1 North America Multiple Sclerosis Drugs Treatment Market Size and Market Share by Players (2015-2020)
6.2 North America Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)
7 Europe Multiple Sclerosis Drugs Treatment by Players and by Application
7.1 Europe Multiple Sclerosis Drugs Treatment Market Size and Market Share by Players (2015-2020)
7.2 Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)
8 China Multiple Sclerosis Drugs Treatment by Players and by Application
8.1 China Multiple Sclerosis Drugs Treatment Market Size and Market Share by Players (2015-2020)
8.2 China Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)
9 Rest of Asia Pacific Multiple Sclerosis Drugs Treatment by Players and by Application
9.1 Rest of Asia Pacific Multiple Sclerosis Drugs Treatment Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)
10 Latin America Multiple Sclerosis Drugs Treatment by Players and by Application
10.1 Latin America Multiple Sclerosis Drugs Treatment Market Size and Market Share by Players (2015-2020)
10.2 Latin America Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)
11 Middle East & Africa Multiple Sclerosis Drugs Treatment by Players and by Application
11.1 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)
12 Multiple Sclerosis Drugs Treatment Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
1.1 Multiple Sclerosis Drugs Treatment Market Overview
1.1.1 Multiple Sclerosis Drugs Treatment Product Scope
1.1.2 Market Status and Outlook
1.2 Global Multiple Sclerosis Drugs Treatment Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Multiple Sclerosis Drugs Treatment Market Size by Region (2015-2026)
1.4 Global Multiple Sclerosis Drugs Treatment Historic Market Size by Region (2015-2020)
1.5 Global Multiple Sclerosis Drugs Treatment Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2026)
1.6.1 North America Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2026)
1.6.2 Europe Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2026)
1.6.3 China Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2026)
1.6.5 Latin America Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2026)
2 Multiple Sclerosis Drugs Treatment Market Overview by Type
2.1 Global Multiple Sclerosis Drugs Treatment Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Multiple Sclerosis Drugs Treatment Historic Market Size by Type (2015-2020)
2.3 Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Type (2021-2026)
2.4 Interferon
2.5 Immunomodulator
2.6 Immunosuppressant
3 Multiple Sclerosis Drugs Treatment Market Overview by Application
3.1 Global Multiple Sclerosis Drugs Treatment Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Multiple Sclerosis Drugs Treatment Historic Market Size by Application (2015-2020)
3.3 Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Application (2021-2026)
3.4 Hospital Pharmacy
3.5 Retail Pharmacy
3.6 Online Pharmacy
3.7 Other
4 Global Multiple Sclerosis Drugs Treatment Competition Analysis by Players
4.1 Global Multiple Sclerosis Drugs Treatment Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Sclerosis Drugs Treatment as of 2019)
4.3 Date of Key Manufacturers Enter into Multiple Sclerosis Drugs Treatment Market
4.4 Global Top Players Multiple Sclerosis Drugs Treatment Headquarters and Area Served
4.5 Key Players Multiple Sclerosis Drugs Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Multiple Sclerosis Drugs Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business and Company’s Total Revenue
5.1.3 Pfizer Products, Services and Solutions
5.1.4 Pfizer Revenue (US$ Million) (2015-2020)
5.1.5 Pfizer Recent Development and Reaction to Covid-19
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business and Company’s Total Revenue
5.2.3 Roche Products, Services and Solutions
5.2.4 Roche Revenue (US$ Million) (2015-2020)
5.2.5 Roche Recent Development and Reaction to Covid-19
5.3 Biogen
5.5.1 Biogen Profile
5.3.2 Biogen Main Business and Company’s Total Revenue
5.3.3 Biogen Products, Services and Solutions
5.3.4 Biogen Revenue (US$ Million) (2015-2020)
5.3.5 Teva Pharmaceutical Recent Development and Reaction to Covid-19
5.4 Teva Pharmaceutical
5.4.1 Teva Pharmaceutical Profile
5.4.2 Teva Pharmaceutical Main Business and Company’s Total Revenue
5.4.3 Teva Pharmaceutical Products, Services and Solutions
5.4.4 Teva Pharmaceutical Revenue (US$ Million) (2015-2020)
5.4.5 Teva Pharmaceutical Recent Development and Reaction to Covid-19
5.5 Merck
5.5.1 Merck Profile
5.5.2 Merck Main Business and Company’s Total Revenue
5.5.3 Merck Products, Services and Solutions
5.5.4 Merck Revenue (US$ Million) (2015-2020)
5.5.5 Merck Recent Development and Reaction to Covid-19
5.6 Novartis
5.6.1 Novartis Profile
5.6.2 Novartis Main Business and Company’s Total Revenue
5.6.3 Novartis Products, Services and Solutions
5.6.4 Novartis Revenue (US$ Million) (2015-2020)
5.6.5 Novartis Recent Development and Reaction to Covid-19
5.7 Bayer
5.7.1 Bayer Profile
5.7.2 Bayer Main Business and Company’s Total Revenue
5.7.3 Bayer Products, Services and Solutions
5.7.4 Bayer Revenue (US$ Million) (2015-2020)
5.7.5 Bayer Recent Development and Reaction to Covid-19
5.8 Sanofi
5.8.1 Sanofi Profile
5.8.2 Sanofi Main Business and Company’s Total Revenue
5.8.3 Sanofi Products, Services and Solutions
5.8.4 Sanofi Revenue (US$ Million) (2015-2020)
5.8.5 Sanofi Recent Development and Reaction to Covid-19
5.9 Acorda Therapeutics
5.9.1 Acorda Therapeutics Profile
5.9.2 Acorda Therapeutics Main Business and Company’s Total Revenue
5.9.3 Acorda Therapeutics Products, Services and Solutions
5.9.4 Acorda Therapeutics Revenue (US$ Million) (2015-2020)
5.9.5 Acorda Therapeutics Recent Development and Reaction to Covid-19
5.10 Questcor Pharmaceuticals
5.10.1 Questcor Pharmaceuticals Profile
5.10.2 Questcor Pharmaceuticals Main Business and Company’s Total Revenue
5.10.3 Questcor Pharmaceuticals Products, Services and Solutions
5.10.4 Questcor Pharmaceuticals Revenue (US$ Million) (2015-2020)
5.10.5 Questcor Pharmaceuticals Recent Development and Reaction to Covid-19
5.11 AbbVie
5.11.1 AbbVie Profile
5.11.2 AbbVie Main Business and Company’s Total Revenue
5.11.3 AbbVie Products, Services and Solutions
5.11.4 AbbVie Revenue (US$ Million) (2015-2020)
5.11.5 AbbVie Recent Development and Reaction to Covid-19
5.12 Opexa Therapeutics
5.12.1 Opexa Therapeutics Profile
5.12.2 Opexa Therapeutics Main Business and Company’s Total Revenue
5.12.3 Opexa Therapeutics Products, Services and Solutions
5.12.4 Opexa Therapeutics Revenue (US$ Million) (2015-2020)
5.12.5 Opexa Therapeutics Recent Development and Reaction to Covid-19
5.13 Genzyme Corporation
5.13.1 Genzyme Corporation Profile
5.13.2 Genzyme Corporation Main Business and Company’s Total Revenue
5.13.3 Genzyme Corporation Products, Services and Solutions
5.13.4 Genzyme Corporation Revenue (US$ Million) (2015-2020)
5.13.5 Genzyme Corporation Recent Development and Reaction to Covid-19
6 North America Multiple Sclerosis Drugs Treatment by Players and by Application
6.1 North America Multiple Sclerosis Drugs Treatment Market Size and Market Share by Players (2015-2020)
6.2 North America Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)
7 Europe Multiple Sclerosis Drugs Treatment by Players and by Application
7.1 Europe Multiple Sclerosis Drugs Treatment Market Size and Market Share by Players (2015-2020)
7.2 Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)
8 China Multiple Sclerosis Drugs Treatment by Players and by Application
8.1 China Multiple Sclerosis Drugs Treatment Market Size and Market Share by Players (2015-2020)
8.2 China Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)
9 Rest of Asia Pacific Multiple Sclerosis Drugs Treatment by Players and by Application
9.1 Rest of Asia Pacific Multiple Sclerosis Drugs Treatment Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)
10 Latin America Multiple Sclerosis Drugs Treatment by Players and by Application
10.1 Latin America Multiple Sclerosis Drugs Treatment Market Size and Market Share by Players (2015-2020)
10.2 Latin America Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)
11 Middle East & Africa Multiple Sclerosis Drugs Treatment by Players and by Application
11.1 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)
12 Multiple Sclerosis Drugs Treatment Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
